EUVIMEDEUVIMED entdecken
Crossref

DNA methylation biomarkers for cervical cancer risk prediction in HIV ‐positive Nigerian women

Yinan Zheng iD, Jingzhe Han, Yishu Qu, Jun Wang, Brian T Joyce, Kyeezu Kim, Drew R Nannini, Jonah Musa, Godwin E Imade, Rose Anorlu, Mamoudou Maiga, Imran Morhason-Bello und 19 weitere

International Journal of Cancer · 2025

DOI: 10.1002/ijc.35502 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Cancer, 2025. Verfasst von Yinan Zheng und 30 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cancer Epidemiology and Prevention, Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illi…. Hauptthemen laut MEDLINE: DNA Methylation, Uterine Cervical Neoplasms, Biomarkers, Tumor, HIV Infections. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: National Cancer Institute of the National Institutes of Health, Fogarty International Center of the National Institutes of Health, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cervical cancer (CC) remains a significant public health issue in low‐ and middle‐income countries (LMICs), especially in Western sub‐Saharan Africa and Nigeria. While global CC incidence and mortality have declined, these regions continue to face high rates due to inadequate screening and the high prevalence of HIV, which increases CC risk by promoting persistent HPV infections. This study aimed to identify DNA methylation (DNAm) biomarkers for cervical intraepithelial neoplasia (CIN) and CC in HIV‐positive Nigerian women and to assess their potential for clinical risk prediction. From 2018 to 2020, 538 participants were recruited from Nigerian tertiary hospitals. Cervical tissue samples were analyzed for DNAm using the Infinium MethylationEPIC BeadChip array, and HPV genotyping was conducted via next‐generation sequencing. An epigenome‐wide association study revealed 24 significant DNAm biomarkers associated with CIN and CC. These biomarkers showed hypermethylation in tumor suppressor genes (e.g., PRMD8 ), hypomethylation in oncogenes (e.g., MIR520H ), and aberrant methylation in genes related to HIV/HPV infection and oncogenesis (e.g., GNB5 , LMO4 , FOXK2 , NMT1 ). A machine learning‐based DNAm classifier achieved 92.9% sensitivity and 88.6% specificity in predicting CC risk, with higher risk observed in adjacent normal cervical samples from CIN/CC patients and HIV/HPV co‐infected women. DNAm biomarkers offer a promising approach to enhancing CC screening and early detection, particularly for HIV‐positive women in LMICs. The DNAm‐based model developed in this study shows potential for more accurate CC risk stratification, highlighting the need for further optimization, validation, and implementation in low‐resource settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA MethylationUterine Cervical NeoplasmsBiomarkers, TumorHIV InfectionsUterine Cervical DysplasiaHumansFemaleAdultNigeriaMiddle AgedPapillomavirus InfectionsRisk Factors

Stichwörter der Autor:innen

DNA methylationHIVHPVcervical cancerepigenome‐wide association study

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Division of Cancer Epidemiology and Prevention, Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Robert J. Havey MD Institute for Global Health, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Sungkyunkwan University School of Medicine, Suwon, South Korea.
  • Department of Obstetrics and Gynecology, College of Health Sciences, University of Jos, Jos, Nigeria.
  • Genomics and Postgraduate Core Facility, College of Health Sciences, University of Jos, Jos, Nigeria.
  • Department of Obstetrics and Gynecology, College of Medicine, University of Lagos, Lagos, Nigeria.

ORCID-Profile: Yinan Zheng

Förderung

  • National Cancer Institute of the National Institutes of Health
  • Fogarty International Center of the National Institutes of Health
  • NCI NIH HHS
  • FIC NIH HHS

Zitieren

APA

Zheng, Y., Han, J., Qu, Y., Wang, J., Joyce, B. T., Kim, K., Nannini, D. R., Musa, J., Imade, G. E., Anorlu, R., Maiga, M., Morhason-Bello, I., Simon, M. A., Silas, O., Abdulkareem, F. B., Badmos, K., Nyam, C. J., Gursel, D. B., Wei, J. J., …, & Hou, L. (2025). DNA methylation biomarkers for cervical cancer risk prediction in HIV ‐positive Nigerian women. International Journal of Cancer. https://doi.org/10.1002/ijc.35502

Vancouver

Zheng Y, Han J, Qu Y, Wang J, Joyce BT, Kim K, et al. DNA methylation biomarkers for cervical cancer risk prediction in HIV ‐positive Nigerian women. International Journal of Cancer. 2025. doi:10.1002/ijc.35502

BibTeX
@article{Zheng2025,
  author = {Zheng, Yinan and Han, Jingzhe and Qu, Yishu and Wang, Jun and Joyce, Brian T and Kim, Kyeezu and Nannini, Drew R and Musa, Jonah and Imade, Godwin E and Anorlu, Rose and Maiga, Mamoudou and Morhason-Bello, Imran and Simon, Melissa A and Silas, Olugbenga and Abdulkareem, Fatimah B and Badmos, Kabir and Nyam, Chuwang J and Gursel, Demirkan B and Wei, Jian-Jun and Novo, Jorge and Sulaimon, Akanmu A and Kayat, Laith S and Kocherginsky, Masha and Kim, Kwang-Youn A and Burdett, Kirsten and Katam, Neelima and Achenbach, Chad J and Sagay, Atiene S and Ogunsola, Folasade T and Murphy, Robert L and Hou, Lifang},
  title = {DNA methylation biomarkers for cervical cancer risk prediction in HIV ‐positive Nigerian women},
  journal = {International Journal of Cancer},
  year = {2025},
  doi = {10.1002/ijc.35502}
}
Kostenlos starten →